Avanos Historical Financial Ratios
AVNS Stock | USD 15.06 0.15 0.99% |
Avanos Medical is presently reporting on over 112 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Ptb Ratio of 1.45, Days Sales Outstanding of 54.63 or Book Value Per Share of 32.46 will help investors to properly organize and evaluate Avanos Medical financial condition quickly.
Avanos |
About Avanos Financial Ratios Analysis
Avanos MedicalFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Avanos Medical investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Avanos financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Avanos Medical history.
Avanos Medical Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Avanos Medical stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Avanos Medical sales, a figure that is much harder to manipulate than other Avanos Medical multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Book Value Per Share
The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.Most ratios from Avanos Medical's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Avanos Medical current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avanos Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy Avanos Stock please use our How to Invest in Avanos Medical guide.At this time, Avanos Medical's Capex To Revenue is comparatively stable compared to the past year. Cash Per Share is likely to gain to 2.46 in 2025, whereas Operating Cash Flow Per Share is likely to drop 0.76 in 2025.
2022 | 2024 | 2025 (projected) | |
PTB Ratio | 0.98 | 0.97 | 1.45 |
Price To Sales Ratio | 1.55 | 1.4 | 1.49 |
Avanos Medical fundamentals Correlations
Click cells to compare fundamentals
Avanos Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Avanos Medical fundamentals Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Price To Sales Ratio | 2.3 | 3.07 | 2.24 | 1.55 | 1.4 | 1.49 | |
Ptb Ratio | 1.75 | 1.32 | 0.98 | 0.85 | 0.97 | 1.45 | |
Days Sales Outstanding | 85.74 | 57.94 | 74.74 | 77.41 | 70.47 | 54.63 | |
Book Value Per Share | 26.29 | 26.28 | 27.53 | 26.53 | 30.51 | 32.46 | |
Free Cash Flow Yield | (0.0104) | 0.0398 | 0.0564 | 0.014 | 0.0161 | 0.0295 | |
Operating Cash Flow Per Share | (0.0523) | 1.81 | 1.94 | 0.7 | 0.8 | 0.76 | |
Stock Based Compensation To Revenue | 0.0169 | 0.0177 | 0.0194 | 0.0235 | 0.0211 | 0.0222 | |
Capex To Depreciation | 1.37 | 0.47 | 0.55 | 0.4 | 0.39 | 0.37 | |
Pb Ratio | 1.75 | 1.32 | 0.98 | 0.85 | 0.97 | 1.45 | |
Ev To Sales | 2.47 | 3.26 | 2.33 | 1.73 | 0.0909 | 0.0863 | |
Free Cash Flow Per Share | (0.47) | 1.38 | 1.53 | 0.31 | 0.36 | 0.34 | |
Roic | (0.0135) | 0.005374 | 0.0354 | 0.003558 | (0.41) | (0.39) | |
Net Income Per Share | (0.57) | 0.13 | 1.08 | (1.33) | (1.53) | (1.45) | |
Days Of Inventory On Hand | 180.52 | 144.25 | 187.73 | 202.89 | 165.29 | 113.57 | |
Payables Turnover | 5.05 | 6.74 | 5.45 | 5.21 | 5.64 | 6.25 | |
Research And Ddevelopement To Revenue | 0.0488 | 0.0434 | 0.0373 | 0.0404 | 0.0381 | 0.0295 | |
Capex To Revenue | 0.0283 | 0.0282 | 0.0235 | 0.0264 | 0.0259 | 0.0422 | |
Cash Per Share | 4.31 | 2.33 | 2.46 | 2.72 | 1.88 | 1.69 | |
Pocfratio | (877.23) | 19.1 | 13.96 | 32.26 | 37.1 | 38.95 | |
Interest Coverage | (2.96) | 2.7 | 7.4 | 0.28 | 32.48 | 30.85 | |
Capex To Operating Cash Flow | (8.08) | 0.24 | 0.21 | 0.55 | 0.18 | 0.19 | |
Pfcf Ratio | (96.61) | 25.15 | 17.73 | 71.59 | 82.33 | 86.45 | |
Days Payables Outstanding | 72.25 | 54.13 | 66.98 | 69.99 | 64.66 | 70.09 | |
Income Quality | 0.0919 | 16.79 | 1.8 | (0.52) | (0.26) | (0.24) | |
Roe | (0.0216) | 0.004985 | 0.0391 | (0.05) | (0.47) | (0.45) | |
Ev To Operating Cash Flow | (932.15) | 19.89 | 15.64 | 36.01 | 0.62 | 0.65 | |
Pe Ratio | (80.63) | 264.7 | 25.13 | (16.91) | (15.22) | (14.46) | |
Return On Tangible Assets | (0.0382) | 0.009666 | 0.0705 | (0.0941) | (0.67) | (0.64) | |
Ev To Free Cash Flow | (102.66) | 26.19 | 19.85 | 79.91 | 0.75 | 0.72 | |
Intangibles To Total Assets | 0.55 | 0.57 | 0.59 | 0.6 | 0.49 | 0.62 | |
Net Debt To E B I T D A | (68.65) | 7.75 | 1.96 | 2.4 | (0.16) | (0.17) | |
Current Ratio | 2.53 | 2.81 | 3.01 | 2.69 | 2.08 | 2.37 | |
Tangible Book Value Per Share | 6.2 | 6.68 | 4.71 | 4.31 | 4.95 | 5.47 | |
Graham Number | 18.35 | 8.8 | 25.83 | 28.14 | 32.36 | 35.68 | |
Shareholders Equity Per Share | 26.29 | 26.28 | 27.53 | 26.53 | 30.51 | 32.46 | |
Debt To Equity | 0.2 | 0.15 | 0.22 | 0.17 | 0.21 | 0.29 | |
Capex Per Share | 1.04 | 1.06 | 0.42 | 0.44 | 0.41 | 0.38 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Avanos Stock Analysis
When running Avanos Medical's price analysis, check to measure Avanos Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avanos Medical is operating at the current time. Most of Avanos Medical's value examination focuses on studying past and present price action to predict the probability of Avanos Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avanos Medical's price. Additionally, you may evaluate how the addition of Avanos Medical to your portfolios can decrease your overall portfolio volatility.